Healthcare & Medical Equipment Suppliers Sector Financials, Performance and Ratios
-
Sector Score
48.7 /100
Rank 13 out of 27 Sectors -
Advance/Decline
183/35
-
No. of Companies218
-
Avg. Market Cap9,956
-
Price to Earning Ratio30.87
-
Price to Earning Growth Ratio2.53
-
Price to Book Ratio6.98
-
Return on Equity25.34
-
Return on Capital Employed-
-
Return on Assets9.48
-
Dividend yield 1 year %0.25 %
-
Net Profit Growth Annual YoY %8.92 %
-
Net Profit Growth Qtr YoY %44.69 %
-
Net Profit Growth Qtr QoQ %-1.23 %
Show more
*All values are market cap weighted averages.
*All Financial parameters are in Million USD.
Healthcare & Medical Equipment Suppliers Sector Market Breadth
- < -5%
- -2 to -5%
- 0 to -2%
- 0 to 2%
- 2 to 5%
- > 5%
Healthcare & Medical Equipment Suppliers Peer comparison
Compare all stocks in Healthcare & Medical Equipment Suppliers industry listed on stock exchanges
Stock Name | 3M Price Chart | Market Cap | LTPLast Traded Price | Day High Low (%) | Week High Low (%) | Month High Low (%) | Qtr High Low(%) | 1 Year High low(%) | 3 Year High low(%) | 5 Year High low(%) | 10 Year High low(%) |
---|---|---|---|---|---|---|---|---|---|---|---|
Agilent Tech |
|
35,928.0
|
126.7
|
L
 2.1%
H
124.9
127.0
|
L
 -1.4%
H
124.0
131
|
L
 11.0%
H
114.4
131
|
L
 5.9%
H
110.8
131
|
L
 -8.6%
H
96.4
153.8
|
L
 -7.9%
H
96.4
160.3
|
L
 28.5%
H
95.4
179.6
|
L
 252.4%
H
33.1
179.6
|
Amerisource Bergen Corp |
|
-
|
302.8
|
L
 2.2%
H
295.7
303.6
|
L
 3.5%
H
290.0
303.6
|
L
 4.2%
H
278.2
306.3
|
L
 5.6%
H
273.4
306.3
|
L
 4.3%
H
273.4
306.3
|
L
 105.6%
H
135.1
306.3
|
L
 221.9%
H
92
306.3
|
L
 190.2%
H
68.4
306.3
|
Abbott |
|
230,871.9
|
132.7
|
L
 2.5%
H
129.4
132.7
|
L
 -0.1%
H
127.4
134.3
|
L
 1.0%
H
127.4
134.3
|
L
 -1.9%
H
119.8
139.1
|
L
 13.8%
H
110.9
141.2
|
L
 22.3%
H
89.7
141.2
|
L
 26.7%
H
89.7
142.6
|
L
 205.6%
H
36
142.6
|
Alcon Inc Registered Shares |
|
39,393.8
|
79.7
|
L
 2.3%
H
77.7
79.7
|
L
 1.0%
H
77.4
80.9
|
L
 -5.9%
H
77.4
90.4
|
L
 -10.1%
H
77.4
92.6
|
L
 -18.9%
H
77.4
101.1
|
L
 16.2%
H
55.2
101.1
|
L
 40.4%
H
55.2
101.1
|
L
H
39.4
101.1
|
Artivion Inc |
|
1,996.3
|
42.3
|
L
 3.1%
H
41
42.3
|
L
 -3.9%
H
40.8
44.2
|
L
 -1.5%
H
40.8
45.1
|
L
 45.7%
H
28.1
45.1
|
L
 73.9%
H
22.0
45.1
|
L
 90.2%
H
9.6
45.1
|
L
 156.9%
H
9.6
45.1
|
L
 338.9%
H
8.9
45.1
|
Avanos Medical Inc |
|
575.9
|
12.4
|
L
 3.2%
H
12
12.4
|
L
 -2.0%
H
11.9
13
|
L
 18.0%
H
10.5
13
|
L
 0.7%
H
9.3
13
|
L
 -47.2%
H
9.3
25.4
|
L
 -51.2%
H
9.3
32.0
|
L
 -60.0%
H
9.3
53.6
|
L
 -62.7%
H
9.3
73.0
|
Baxter International |
|
12,578.6
|
24.5
|
L
 2.1%
H
23.9
24.5
|
L
 3.9%
H
23.6
24.6
|
L
 4.4%
H
23.1
24.9
|
L
 -22.0%
H
21.3
31.8
|
L
 -37.6%
H
21.3
40.5
|
L
 -58.9%
H
21.3
60.4
|
L
 -70.5%
H
21.3
89.7
|
L
 -32.0%
H
21.3
95.2
|
Becton, Dickinson & Company |
|
54,619.7
|
190.6
|
L
 1.1%
H
188.2
191.3
|
L
 -0.4%
H
187.0
193.0
|
L
 -1.0%
H
183.7
200.2
|
L
 10.3%
H
167.5
200.2
|
L
 -18.5%
H
163.3
251.9
|
L
 -27.5%
H
163.3
287.3
|
L
 -17.2%
H
163.3
287.3
|
L
 43.6%
H
125.7
287.3
|
Butterfly Network Inc |
|
390.2
|
1.6
|
L
 3.3%
H
1.5
1.6
|
L
 1.3%
H
1.5
1.6
|
L
 14.0%
H
1.3
1.7
|
L
 -38.5%
H
1.3
2.5
|
L
 -19.7%
H
1.3
5.0
|
L
 -76.0%
H
0.7
6.8
|
L
 -84.2%
H
0.7
29.1
|
L
H
0.7
29.1
|
BioRad Laboratories Inc |
|
7,737.2
|
285.9
|
L
 3.3%
H
278.2
286.5
|
L
 -1.2%
H
276.5
298
|
L
 8.1%
H
264.3
308.4
|
L
 24.2%
H
222.8
308.4
|
L
 -10.4%
H
211.4
388.0
|
L
 -43.9%
H
211.4
514.3
|
L
 -43.4%
H
211.4
832.7
|
L
 104.9%
H
122.0
832.7
|
Bausch Lomb Corp |
|
5,421.2
|
15.3
|
L
 2.1%
H
15.1
15.5
|
L
 5%
H
14.6
15.6
|
L
 12.4%
H
13.6
15.6
|
L
 22.5%
H
11.4
15.6
|
L
 -3.2%
H
10.5
21.7
|
L
 -10.8%
H
10.5
22.0
|
L
H
10.5
22.0
|
L
H
10.5
22.0
|
Boston Scientific |
|
154,606.0
|
104.3
|
L
 -0.9%
H
103.5
105.7
|
L
 -2.8%
H
103.5
109.5
|
L
 1.6%
H
101.6
109.5
|
L
 5.0%
H
98
109.5
|
L
 25.8%
H
80.6
109.5
|
L
 143.0%
H
37.7
109.5
|
L
 159.0%
H
33.0
109.5
|
L
 517.8%
H
15.7
109.5
|
Cardinal Health |
|
36,408.9
|
152.5
|
L
 2.1%
H
149.4
152.8
|
L
 2.1%
H
148.1
152.8
|
L
 -3.3%
H
137.8
153.7
|
L
 -0.7%
H
137.8
168.4
|
L
 34.5%
H
106.5
168.4
|
L
 118.2%
H
65.0
168.4
|
L
 215.2%
H
44.7
168.4
|
L
 79.4%
H
39.1
168.4
|
Conmed Corp |
|
1,673.1
|
54.1
|
L
 2.4%
H
52.7
54.1
|
L
 -1.2%
H
52.4
56.6
|
L
 3.0%
H
52
56.6
|
L
 -5.1%
H
47.3
56.6
|
L
 -26.3%
H
46
78.2
|
L
 -44.9%
H
46
138.5
|
L
 -37.5%
H
46
159.1
|
L
 5.0%
H
35.5
159.1
|
Cooper Companies |
|
13,610.5
|
68.5
|
L
 1.2%
H
67.7
68.7
|
L
 0.7%
H
67.3
69.8
|
L
 -3.4%
H
61.8
75.5
|
L
 -4.1%
H
61.8
77.1
|
L
 -36.9%
H
61.8
112.4
|
L
 -13.0%
H
61.1
112.4
|
L
 -16.2%
H
61.1
115.9
|
L
 83.0%
H
29.8
115.9
|
Danaher |
|
139,744.6
|
195.2
|
L
 1.3%
H
193.5
196.2
|
L
 -1.9%
H
192.4
203.9
|
L
 -2.3%
H
192.2
214.0
|
L
 -4.7%
H
185.5
214.0
|
L
 -28.2%
H
171.0
279.6
|
L
 -32.8%
H
171.0
294.6
|
L
 -4.7%
H
171.0
334.0
|
L
 196.5%
H
61.6
334.0
|
Edwards Lifesciences |
|
45,799.7
|
78.0
|
L
 -0.3%
H
77.1
78.5
|
L
 -3.6%
H
77.1
81.6
|
L
 -0.2%
H
76.1
82.7
|
L
 3.4%
H
72.4
83
|
L
 14.3%
H
64
83
|
L
 -19.8%
H
58.9
98.4
|
L
 -4.6%
H
58.9
131.7
|
L
 236.4%
H
22.2
131.7
|
Glaukos Corporation |
|
5,016.4
|
87.5
|
L
 -0.1%
H
87.1
89.3
|
L
 -3.0%
H
86.8
95.3
|
L
 0.5%
H
85.9
97
|
L
 -11.8%
H
82.9
106.8
|
L
 -30.3%
H
77.1
163.7
|
L
 55.4%
H
40.5
163.7
|
L
 86.1%
H
33.3
163.7
|
L
 175.9%
H
14.3
163.7
|
Globus Medical Inc Ordinary |
|
8,052.1
|
59.6
|
L
 2.0%
H
58.4
59.7
|
L
 -1.1%
H
58.2
61.2
|
L
 0.3%
H
58.2
63.1
|
L
 -1.9%
H
51.8
63.1
|
L
 -13.9%
H
51.8
94.9
|
L
 -5.1%
H
43.4
94.9
|
L
 8.3%
H
43.4
94.9
|
L
 154.1%
H
19.3
94.9
|
Haemonetics Corp |
|
2,576.5
|
53.5
|
L
 -0.4%
H
53.4
54
|
L
 -1.1%
H
53.1
54.8
|
L
 1.9%
H
50.7
56.6
|
L
 -25.2%
H
50.7
79.9
|
L
 -26.2%
H
50.7
95.0
|
L
 -30.4%
H
50.7
98.0
|
L
 -39.7%
H
43.5
142.1
|
L
 49.9%
H
26.0
142.1
|
Herbalife Nutrition |
|
964.0
|
9.4
|
L
 0.7%
H
9.2
9.4
|
L
 -7.3%
H
9.2
10.3
|
L
 4.9%
H
8.9
10.3
|
L
 16.6%
H
7.6
10.8
|
L
 29.7%
H
5.0
10.8
|
L
 -62.6%
H
5.0
25.7
|
L
 -80.8%
H
5.0
59
|
L
 -66.6%
H
5.0
61.8
|
Inspire Medical Systems Inc |
|
2,448.8
|
82.8
|
L
 5.1%
H
78.8
82.8
|
L
 -4.1%
H
77.4
87.7
|
L
 4.0%
H
77.4
97.3
|
L
 -37.6%
H
73.9
144.0
|
L
 -59.9%
H
73.9
218.5
|
L
 -60.2%
H
73.9
330
|
L
 -35.0%
H
73.9
330
|
L
H
22.5
330
|
Integer Holdings Corp |
|
3,651.7
|
104.2
|
L
 1.7%
H
102.1
104.7
|
L
 -2.2%
H
101.6
108.4
|
L
 -1.1%
H
101.6
111.0
|
L
 -13.2%
H
101.6
123.8
|
L
 -16.1%
H
101.6
146.4
|
L
 60.2%
H
50.1
146.4
|
L
 62.1%
H
50.1
146.4
|
L
 86.9%
H
18.1
146.4
|
McKesson |
|
89,531.9
|
719.8
|
L
 1.9%
H
706
727.3
|
L
 4.1%
H
682.4
727.3
|
L
 7.0%
H
637
727.3
|
L
 0.3%
H
637
737.9
|
L
 41.0%
H
464.4
737.9
|
L
 96.6%
H
331.8
737.9
|
L
 378.7%
H
141.3
737.9
|
L
 264.2%
H
106.1
737.9
|
Medtronic |
|
120,893.1
|
94.3
|
L
 2.1%
H
92.3
94.3
|
L
 1.5%
H
91.4
94.3
|
L
 1.6%
H
87.5
94.4
|
L
 7.0%
H
84.6
94.4
|
L
 4.3%
H
79.3
96.3
|
L
 5.0%
H
68.9
96.3
|
L
 -10.0%
H
68.9
135.9
|
L
 34.8%
H
64.0
135.9
|
Mettler-Toledo International |
|
26,422.8
|
1,282.7
|
L
 2.4%
H
1245.0
1285.8
|
L
 -0.4%
H
1245.0
1317.0
|
L
 2.1%
H
1245.0
1340.9
|
L
 7.5%
H
1131.6
1340.9
|
L
 -7.6%
H
946.7
1521.0
|
L
 -1.4%
H
928.5
1616.0
|
L
 31.7%
H
928.5
1714.8
|
L
 327.9%
H
275.3
1714.8
|
Envista Holdings Corp |
|
3,591.2
|
21.6
|
L
 4.0%
H
20.7
21.6
|
L
 4.0%
H
20.6
21.6
|
L
 7.2%
H
20.1
21.7
|
L
 12.4%
H
18.3
21.7
|
L
 22.5%
H
14.2
23
|
L
 -43.0%
H
14.2
43.3
|
L
 -13.5%
H
14.2
52.0
|
L
H
10.1
52.0
|
Owens Minor Inc |
|
422.5
|
5.5
|
L
 -0.2%
H
5.2
5.6
|
L
 1.3%
H
5.1
5.7
|
L
 18.1%
H
4.6
5.9
|
L
 -30.3%
H
4.6
9.6
|
L
 -62.5%
H
4.6
16.5
|
L
 -80.6%
H
4.6
29.4
|
L
 -65.2%
H
4.6
49.2
|
L
 -83.9%
H
2.4
49.2
|
Penumbra Inc |
|
10,779.4
|
276.4
|
L
 1.6%
H
273.2
278.5
|
L
 -1.2%
H
270.5
288.9
|
L
 15.4%
H
239.1
288.9
|
L
 9.1%
H
225.5
288.9
|
L
 36.6%
H
184.8
310
|
L
 34.3%
H
144.8
348.7
|
L
 38.6%
H
114.9
348.7
|
L
H
30
348.7
|
Koninklijke Philips NV ADR |
|
27,205.4
|
28.6
|
L
 1.2%
H
28.3
28.7
|
L
 3.2%
H
27.7
28.7
|
L
 7.3%
H
26.8
28.7
|
L
 21.2%
H
22.0
28.7
|
L
 -6.0%
H
21.5
32.9
|
L
 59.4%
H
11.8
32.9
|
L
 -39.3%
H
11.8
61.2
|
L
 12.9%
H
11.8
61.2
|
Qiagen NV |
|
9,987.4
|
46.1
|
L
 0.1%
H
45.3
46.2
|
L
 -2.1%
H
45.3
47.9
|
L
 -4.1%
H
45.3
50.0
|
L
 -1.4%
H
45.3
51.9
|
L
 -2.3%
H
37.6
51.9
|
L
 -5.9%
H
36.8
54.3
|
L
 -12.3%
H
36.8
62.6
|
L
 56.8%
H
22.0
62.6
|
Vicarious Surgical Inc |
|
34.6
|
5.8
|
L
 2.8%
H
5.7
6.0
|
L
 1.9%
H
5.6
6.4
|
L
 -36.7%
H
5.6
10.5
|
L
 -28.0%
H
5.6
13.8
|
L
 3.9%
H
5
19
|
L
 -99.9%
H
4.3
4104
|
L
 -99.9%
H
4.3
14207.0
|
L
H
4.3
14207.0
|
ResMed |
|
40,207.0
|
274.6
|
L
 1.5%
H
270.4
275.3
|
L
 0.3%
H
265.7
281.3
|
L
 -3.4%
H
265.5
293.8
|
L
 9.3%
H
248.2
293.8
|
L
 8.6%
H
199.9
293.8
|
L
 16.3%
H
132.2
293.8
|
L
 59.7%
H
132.2
301.3
|
L
 433.4%
H
49.1
301.3
|
STERIS (Ireland) |
|
24,862.0
|
252.4
|
L
 3.5%
H
243.0
252.6
|
L
 3.7%
H
242.6
252.6
|
L
 4.5%
H
239.4
252.6
|
L
 4.9%
H
220.6
252.6
|
L
 4.3%
H
201.0
252.8
|
L
 20.0%
H
159.2
254
|
L
 55.6%
H
159.2
255.9
|
L
 290.4%
H
61.4
255.9
|
Stevanato Group Spa |
|
7,335.1
|
26.9
|
L
 4.0%
H
25.9
27.2
|
L
 16.6%
H
23.3
27.2
|
L
 23.0%
H
21.5
27.2
|
L
 8.5%
H
21.5
28
|
L
 33.0%
H
17.1
28
|
L
 50.7%
H
13.7
36.3
|
L
H
13.4
36.3
|
L
H
13.4
36.3
|
Stryker |
|
148,637.3
|
388.8
|
L
 1.5%
H
383.0
389.4
|
L
 -1.4%
H
381.5
396.4
|
L
 3.2%
H
374.5
396.9
|
L
 2.0%
H
370.9
404.9
|
L
 6.1%
H
329.2
406.2
|
L
 69.0%
H
200.8
406.2
|
L
 92.5%
H
188.8
406.2
|
L
 290.2%
H
86.7
406.2
|
Smith Nephew plc ADR |
|
16,727.5
|
38.5
|
L
 1.5%
H
38.3
38.6
|
L
 2.4%
H
37.9
38.8
|
L
 7.2%
H
36.0
38.8
|
L
 27.9%
H
28.4
38.8
|
L
 22.2%
H
23.7
38.8
|
L
 47.7%
H
21.5
38.8
|
L
 -4.3%
H
21.5
46.1
|
L
 6.6%
H
21.5
52.3
|
Teleflex Incorporated |
|
5,855.5
|
132.5
|
L
 1.7%
H
129.9
133.2
|
L
 2.6%
H
128.3
133.2
|
L
 14.3%
H
116.1
133.2
|
L
 8.2%
H
108.9
133.2
|
L
 -45.8%
H
108.9
249.9
|
L
 -45.3%
H
108.9
276.4
|
L
 -64.2%
H
108.9
449.4
|
L
 -3.7%
H
108.9
449.4
|
Thermo Fisher |
|
185,562.4
|
491.4
|
L
 3.1%
H
480.4
492
|
L
 0.4%
H
475.6
502
|
L
 6.3%
H
460.9
502.4
|
L
 18.4%
H
385.5
502.4
|
L
 -20.5%
H
385.5
623.8
|
L
 -13.7%
H
385.5
627.9
|
L
 14.0%
H
385.5
672.3
|
L
 299.8%
H
117.1
672.3
|
Waters |
|
18,003.1
|
302.5
|
L
 3.2%
H
295.1
303.2
|
L
 0.9%
H
288.9
310.8
|
L
 8.3%
H
278.5
310.8
|
L
 -12.6%
H
275.1
366.7
|
L
 -7.4%
H
275.1
423.6
|
L
 -3.1%
H
231.9
423.6
|
L
 48.3%
H
187.3
428.2
|
L
 142.8%
H
112
428.2
|
West Pharma Services |
|
18,964.8
|
263.7
|
L
 3.3%
H
253.8
264.1
|
L
 6.5%
H
247.1
264.1
|
L
 9.7%
H
237.2
264.1
|
L
 17.7%
H
206.8
291
|
L
 -12.8%
H
187.4
352.3
|
L
 -15.9%
H
187.4
415.7
|
L
 -3.2%
H
187.4
475.4
|
L
 358.8%
H
52.8
475.4
|
Zimmer Biomet |
|
20,653.5
|
104.3
|
L
 1.9%
H
102.0
104.5
|
L
 -0.5%
H
102.0
106.2
|
L
 4.2%
H
99.6
108.3
|
L
 10.6%
H
89.3
108.3
|
L
 -0.9%
H
89.2
114.7
|
L
 -8.9%
H
89.2
149.3
|
L
 -20.4%
H
89.2
169.7
|
L
 10.6%
H
70.0
169.7
|
Haleon plc ADR |
|
44,171.7
|
9.9
|
L
 0.4%
H
9.8
9.9
|
L
 0.3%
H
9.7
9.9
|
L
 4.2%
H
9.5
10.0
|
L
 -9.5%
H
9.2
11.0
|
L
 -5.4%
H
8.9
11.4
|
L
 64.5%
H
5.8
11.4
|
L
H
5.6
11.4
|
L
H
5.6
11.4
|
Revvity |
|
9,945.1
|
85.7
|
L
 3.9%
H
82.6
85.9
|
L
 0.0%
H
82.5
88.1
|
L
 -0.1%
H
81.4
94.7
|
L
 -10.8%
H
81.4
104.4
|
L
 -29.2%
H
81.4
129.5
|
L
 -39.5%
H
79.5
150.2
|
L
 -27.2%
H
79.5
203.2
|
L
 78.7%
H
39.5
203.2
|
Aethlon Medical Inc |
|
2.1
|
0.8
|
L
 21.5%
H
0.6
0.8
|
L
 8.2%
H
0.6
0.8
|
L
 -36.3%
H
0.6
2.7
|
L
 -60.9%
H
0.6
2.7
|
L
 -73.8%
H
0.6
8.4
|
L
 -99.0%
H
0.6
87.2
|
L
 -99.3%
H
0.6
999.2
|
L
 -100.0%
H
0.6
10907.9
|
Airsculpt Technologies Inc |
|
394.0
|
6.3
|
L
 3.4%
H
6.1
6.4
|
L
 7.0%
H
5.7
6.4
|
L
 -3.7%
H
5.7
7.5
|
L
 23.5%
H
4.4
7.5
|
L
 69.6%
H
1.5
9.2
|
L
 -31.8%
H
1.5
9.9
|
L
H
1.5
18.5
|
L
H
1.5
18.5
|
Align Tech |
|
9,851.6
|
135.9
|
L
 2.2%
H
132.9
137.7
|
L
 0.9%
H
132.5
140.4
|
L
 0.8%
H
131
150.2
|
L
 -26.7%
H
127.7
208.3
|
L
 -39.6%
H
127.7
260.9
|
L
 -48.3%
H
127.7
413.2
|
L
 -57.2%
H
127.7
737.5
|
L
 144.7%
H
54.6
737.5
|
Angiodynamic Inc |
|
445.3
|
11.0
|
L
 0.2%
H
10.7
11.0
|
L
 2.1%
H
10.6
11.1
|
L
 29.7%
H
8.5
11.1
|
L
 0.6%
H
8.4
11.1
|
L
 47.7%
H
5.8
13.5
|
L
 -51.5%
H
5.3
22.9
|
L
 20.4%
H
5.3
32
|
L
 -24.5%
H
5.3
32
|
Anika Therapeutics Inc |
|
124.4
|
8.6
|
L
 2.7%
H
8.4
8.9
|
L
 -5.1%
H
8.4
9.5
|
L
 5.1%
H
8.2
9.8
|
L
 -23.7%
H
7.9
11.8
|
L
 -64.4%
H
7.9
26
|
L
 -62.4%
H
7.9
32.5
|
L
 -76.3%
H
7.9
48.4
|
L
 -75.9%
H
7.9
75.7
|
Apyx Medical Corp |
|
75.6
|
2
|
L
 1.5%
H
2.0
2.0
|
L
 -2.4%
H
2.0
2.1
|
L
 -10.3%
H
1.8
2.4
|
L
 13.6%
H
1.6
2.7
|
L
 58.7%
H
0.8
2.7
|
L
 -68.1%
H
0.8
8.0
|
L
 -58.2%
H
0.8
17.5
|
L
 -16.0%
H
0.8
17.5
|
Accuray Inc |
|
179.2
|
1.6
|
L
 2.6%
H
1.6
1.6
|
L
 5.3%
H
1.5
1.6
|
L
 16.9%
H
1.4
1.6
|
L
 27.2%
H
1.2
1.6
|
L
 -19.3%
H
1.1
3.0
|
L
 -33.2%
H
1.1
4.3
|
L
 -29.6%
H
1.1
6.0
|
L
 -75.4%
H
1.1
7.5
|
Alphatec Holdings Inc |
|
2,313.0
|
15.6
|
L
 1.8%
H
15.3
15.7
|
L
 -5.6%
H
15.2
16.7
|
L
 2.0%
H
15.1
16.7
|
L
 33.3%
H
10.1
16.7
|
L
 186.8%
H
4.9
16.7
|
L
 87.4%
H
4.9
19.1
|
L
 160.5%
H
4.9
19.4
|
L
 224.9%
H
1.2
19.4
|
Atricure Inc |
|
1,866.8
|
37.6
|
L
 6.9%
H
35.0
37.7
|
L
 5.3%
H
34.6
37.7
|
L
 5.8%
H
34.4
38.2
|
L
 13.8%
H
29.0
38.2
|
L
 39.6%
H
25.6
43.1
|
L
 -19.1%
H
18.9
59.6
|
L
 -7.6%
H
18.9
89.2
|
L
 51.5%
H
13.4
89.2
|
Axogen Inc |
|
773.0
|
16.8
|
L
 4.5%
H
15.9
17
|
L
 9.1%
H
15.4
17
|
L
 19.9%
H
13.6
17
|
L
 65.2%
H
9.2
17
|
L
 26.5%
H
9.2
21
|
L
 46.1%
H
3.5
21
|
L
 55.6%
H
3.5
23.9
|
L
 246.4%
H
3.5
56.9
|
Bone Biologics Corp |
|
3.4
|
2.1
|
L
 5.5%
H
2.0
2.2
|
L
 -26.0%
H
2.0
2.9
|
L
 -10.6%
H
2.0
4.1
|
L
 -57.0%
H
2.0
6.8
|
L
 -69.2%
H
2.0
16.5
|
L
 -99.9%
H
2.0
2001.6
|
L
 -100.0%
H
2.0
21600
|
L
H
2.0
169920
|
BioAffinity Technologies Inc |
|
7.4
|
0.3
|
L
H
0.2
0.3
|
L
 8.3%
H
0.2
0.3
|
L
 -7.1%
H
0.2
0.3
|
L
 -10.3%
H
0.2
0.5
|
L
 -85.4%
H
0.2
2.3
|
L
 -94.6%
H
0.2
6.8
|
L
H
0.2
15.6
|
L
H
0.2
15.6
|
Bluejay Diagnostics Inc |
|
2.2
|
1.5
|
L
 1.4%
H
1.5
1.5
|
L
 4.3%
H
1.4
1.5
|
L
 -21.8%
H
1.3
1.6
|
L
 -18.3%
H
1.3
2.5
|
L
 880%
H
0.1
10.2
|
L
 -99.1%
H
0.1
168
|
L
H
0.1
1000
|
L
H
0.1
1000
|
Biolife Solutions Inc |
|
1,281.0
|
26.7
|
L
 0.9%
H
26.5
27.5
|
L
 3.4%
H
25.9
27.5
|
L
 19.5%
H
22.2
27.5
|
L
 12.6%
H
20.1
27.5
|
L
 15.3%
H
19.1
29.5
|
L
 0.5%
H
8.9
29.5
|
L
 12.5%
H
8.9
60.7
|
L
 1023.5%
H
1.4
60.7
|
Biomerica Inc |
|
8.3
|
3.0
|
L
 0.7%
H
2.9
3.1
|
L
 4.6%
H
2.5
3.1
|
L
 -2.0%
H
2.5
4.6
|
L
 -14.0%
H
2.5
4.6
|
L
 851.6%
H
0.3
4.9
|
L
 -20.9%
H
0.2
5.3
|
L
 -55.5%
H
0.2
8.2
|
L
 247.1%
H
0.2
23.4
|
Bruker Corp |
|
4,865.6
|
32.1
|
L
 5.2%
H
30.5
32.2
|
L
 7.7%
H
29.8
32.2
|
L
 4.2%
H
28.5
35.9
|
L
 -19.3%
H
28.5
44.8
|
L
 -49.9%
H
28.5
72.9
|
L
 -45.0%
H
28.5
94.9
|
L
 -20.6%
H
28.5
94.9
|
L
 77.2%
H
15.8
94.9
|
BioRestorative Therapies Inc |
|
12.8
|
1.6
|
L
 1.9%
H
1.6
1.6
|
L
 -1.8%
H
1.6
1.7
|
L
 13.5%
H
1.4
1.9
|
L
 -14.9%
H
1.4
2.0
|
L
 8.1%
H
1.2
2.6
|
L
 -50.5%
H
1.0
7.1
|
L
 -98.5%
H
1.0
185.6
|
L
 -100.0%
H
0.4
26600
|
Biosig Technologies Inc |
|
215.2
|
6.1
|
L
 37.1%
H
4.4
6.1
|
L
 33.5%
H
3.8
6.1
|
L
 49.1%
H
3.8
6.1
|
L
 -9.0%
H
3.6
14.1
|
L
 1255.6%
H
0.2
14.1
|
L
 593.2%
H
0.1
14.1
|
L
 -13.8%
H
0.1
14.1
|
L
 48.1%
H
0.1
14.1
|
Bioventus Inc Ordinary Shares |
|
487.0
|
7.3
|
L
 4%
H
7.0
7.3
|
L
 2.5%
H
7.0
7.4
|
L
 5.1%
H
7.0
7.7
|
L
 8.5%
H
5.8
7.7
|
L
 -30.9%
H
5.8
14.4
|
L
 -10.2%
H
0.8
14.4
|
L
H
0.8
19.9
|
L
H
0.8
19.9
|
Brainsway ADR |
|
296.9
|
15.7
|
L
 -1.4%
H
15.5
16.0
|
L
 -1.7%
H
15.3
16.3
|
L
 29.8%
H
11.8
16.3
|
L
 33.8%
H
10.7
16.3
|
L
 102.8%
H
7.7
16.3
|
L
 300.5%
H
1.4
16.3
|
L
 163.9%
H
1.4
16.3
|
L
H
1.4
16.3
|
Cardio Diagnostics Holdings |
|
6.7
|
3.8
|
L
 1.6%
H
3.8
4.0
|
L
 3.5%
H
3.6
4.0
|
L
 9.8%
H
3.3
4.1
|
L
 -9.7%
H
3.2
4.7
|
L
 -56.2%
H
3.2
53.1
|
L
 -98.7%
H
3.2
307.5
|
L
H
3.2
307.5
|
L
H
3.2
307.5
|
Caredx Inc |
|
720.2
|
13.5
|
L
 1.5%
H
13.3
13.8
|
L
 3.3%
H
13.1
14
|
L
 15.0%
H
11.3
14.2
|
L
 -32.6%
H
11.0
20.9
|
L
 -52.6%
H
11.0
33.0
|
L
 -29.5%
H
4.8
34.8
|
L
 -59.1%
H
4.8
99.8
|
L
 91.4%
H
0.8
99.8
|
Celcuity Inc |
|
2,436.6
|
57.4
|
L
 2.7%
H
55.2
59.4
|
L
 5.4%
H
54.6
63.1
|
L
 23.1%
H
46.8
63.1
|
L
 359.8%
H
11.3
63.1
|
L
 269.6%
H
7.6
63.1
|
L
 537.4%
H
7.5
63.1
|
L
 1015.1%
H
4.8
63.1
|
L
H
4.0
63.1
|
Creative Medical Technology |
|
9.0
|
3.5
|
L
 1.5%
H
3.4
3.6
|
L
 6.1%
H
3.2
3.6
|
L
 19.5%
H
2.9
3.6
|
L
 58.6%
H
2.1
4.3
|
L
 1.2%
H
1.7
6.9
|
L
 -51.5%
H
1.7
14.2
|
L
 -80.6%
H
1.7
650
|
L
H
1.7
525000
|
Cerus Corp |
|
239.6
|
1.3
|
L
 5.9%
H
1.2
1.3
|
L
 -6.0%
H
1.2
1.4
|
L
 0.8%
H
1.2
1.4
|
L
 -12.0%
H
1.2
1.6
|
L
 -39.0%
H
1.1
2.2
|
L
 -69.9%
H
1.1
4.3
|
L
 -79.7%
H
1.1
8.9
|
L
 -78.0%
H
1.1
8.9
|
CheckCap |
|
4.0
|
0.7
|
L
 -4.2%
H
0.7
0.7
|
L
 6.2%
H
0.6
0.8
|
L
 3.0%
H
0.6
1.1
|
L
 -14.8%
H
0.6
1.1
|
L
 -61.7%
H
0.6
3.0
|
L
 -89.3%
H
0.6
7.0
|
L
 -90.3%
H
0.6
89.8
|
L
 -99.9%
H
0.6
173376
|
CollPlant Biotechnologies |
|
34.5
|
2.7
|
L
 -0.4%
H
2.6
2.8
|
L
 3.8%
H
2.6
2.9
|
L
 -9.1%
H
1.9
3.2
|
L
 56.7%
H
1.3
3.2
|
L
 -47.2%
H
1.3
5.1
|
L
 -66.0%
H
1.3
14.0
|
L
 -70.2%
H
1.3
24.3
|
L
 -90.3%
H
1.3
24.3
|
ClearPoint Neuro Inc |
|
315.3
|
11.1
|
L
 5.3%
H
10.4
11.5
|
L
 0.1%
H
10.3
11.5
|
L
 4.6%
H
10.1
12.0
|
L
 -13.7%
H
9.9
12.9
|
L
 -9.2%
H
9.8
19.2
|
L
 -13.8%
H
4.1
19.2
|
L
 147.0%
H
4.1
31.3
|
L
 -58.6%
H
1.3
31.3
|
Cardiff Oncology Inc |
|
138.4
|
2.1
|
L
 2.0%
H
2.0
2.1
|
L
 -2.4%
H
2.0
2.3
|
L
 -10.7%
H
1.9
2.6
|
L
 -46.1%
H
1.9
4.6
|
L
 -10.0%
H
1.9
5.6
|
L
 -28.3%
H
0.9
6.4
|
L
 -65.0%
H
0.9
25.5
|
L
 -99.5%
H
0.7
545.6
|
Castle Biosciences Inc |
|
659.9
|
22.8
|
L
 -0.8%
H
22.7
23.6
|
L
 -1.5%
H
22.7
24.7
|
L
 18.7%
H
19.0
24.7
|
L
 23.4%
H
14.6
24.7
|
L
 -26.7%
H
14.6
35.8
|
L
 -22.4%
H
9.3
35.8
|
L
 -53.2%
H
9.3
107.7
|
L
H
9.3
107.7
|
Cytek BioSciences Inc |
|
525.4
|
4.1
|
L
 10.4%
H
3.7
4.1
|
L
 3.8%
H
3.7
4.2
|
L
 9.0%
H
3.7
4.3
|
L
 20.1%
H
2.9
4.3
|
L
 -24.8%
H
2.4
7.6
|
L
 -70.7%
H
2.4
15.9
|
L
H
2.4
28.7
|
L
H
2.4
28.7
|
Cytosorbents Corp |
|
59.6
|
1.0
|
L
 1.1%
H
0.9
1.0
|
L
 -3.1%
H
0.9
1.0
|
L
 -20.8%
H
0.8
1.2
|
L
 -12.8%
H
0.8
1.4
|
L
 -5%
H
0.7
1.6
|
L
 -45.1%
H
0.7
4.6
|
L
 -87.6%
H
0.7
11.7
|
L
 -86.8%
H
0.7
15.0
|
Citius Pharmaceuticals Inc |
|
20.4
|
1.2
|
L
 -0.8%
H
1.2
1.3
|
L
 4.4%
H
1.1
1.3
|
L
 -4%
H
1.1
1.6
|
L
 18.8%
H
0.8
2.5
|
L
 -90.9%
H
0.1
15.3
|
L
 -96.4%
H
0.1
42.8
|
L
 -95.2%
H
0.1
114
|
L
 -99.8%
H
0.1
937.5
|
CVRx Inc |
|
214.8
|
8.2
|
L
 4.6%
H
7.9
8.4
|
L
 7.0%
H
7.6
8.4
|
L
 9.7%
H
6.8
8.4
|
L
 24.7%
H
5.5
8.9
|
L
 1.6%
H
4.3
18.6
|
L
 -1.8%
H
4.3
33.1
|
L
H
4.3
33.1
|
L
H
4.3
33.1
|
Delcath Systems Inc |
|
389.3
|
11.1
|
L
 0.1%
H
11.1
11.3
|
L
 0.3%
H
11.0
11.9
|
L
 5.9%
H
10.1
11.9
|
L
 -30.3%
H
9.9
16.0
|
L
 11.8%
H
8.1
18.2
|
L
 163.7%
H
2.3
18.2
|
L
 -3.8%
H
2.3
25.2
|
L
 -100.0%
H
2.3
1332800000
|
Alpha Tau Medical |
|
325.7
|
3.8
|
L
 2.1%
H
3.7
3.9
|
L
 9.7%
H
3.5
4.0
|
L
 7.6%
H
3
4.0
|
L
 24.8%
H
2.9
4.0
|
L
 71.0%
H
2.1
4.4
|
L
 -37.5%
H
1.8
6.6
|
L
H
1.8
20.7
|
L
H
1.8
20.7
|
DexCom |
|
29,803.8
|
76
|
L
H
75.9
77.9
|
L
 -5.9%
H
75.6
81.6
|
L
 -2.4%
H
73.5
82.4
|
L
 -8.4%
H
73.5
90.0
|
L
 11%
H
57.5
93.2
|
L
 -18.2%
H
57.5
142
|
L
 -20.7%
H
57.5
164.9
|
L
 212.1%
H
10.7
164.9
|
Daxor Corp |
|
55.4
|
11.1
|
L
 -2.3%
H
11.1
11.7
|
L
 -1.9%
H
10.7
11.7
|
L
 10.1%
H
10
11.7
|
L
 27.0%
H
8.5
11.7
|
L
 21.6%
H
6.6
11.7
|
L
 -13.2%
H
6.6
14.4
|
L
 -26.2%
H
6.6
17.6
|
L
 58.7%
H
3.4
24.1
|
ElectroCore Inc |
|
38.1
|
5.0
|
L
 2.2%
H
4.9
5.1
|
L
 2.0%
H
4.7
5.3
|
L
 16.5%
H
4.3
5.7
|
L
 -11.3%
H
4.2
8.6
|
L
 -16.3%
H
4.2
19.5
|
L
 -35.0%
H
2.9
19.5
|
L
 -76.6%
H
2.9
54.5
|
L
H
2.9
303.8
|
Ekso Bionics Holdings Inc |
|
10.2
|
3.9
|
L
 -2.2%
H
3.5
4.1
|
L
 -3.5%
H
3.5
4.2
|
L
 31.5%
H
2.9
4.3
|
L
 -7.3%
H
2.7
5.6
|
L
 -98.5%
H
2.7
288
|
L
 -99.2%
H
2.7
704.0
|
L
 -99.6%
H
2.7
3370.5
|
L
 -100.0%
H
2.7
34020
|
Embecta Corp |
|
895.4
|
15.3
|
L
 2.3%
H
14.9
15.4
|
L
 5.7%
H
14.4
15.4
|
L
 20.3%
H
12.7
15.4
|
L
 51.4%
H
9.2
15.4
|
L
 -1.7%
H
9.2
21.5
|
L
 -52.7%
H
9.2
36.6
|
L
H
9.2
63
|
L
H
9.2
63
|
Establishment Labs Holdings |
|
1,095.4
|
37.8
|
L
 -0.3%
H
37.7
38.9
|
L
 -2.2%
H
37.3
40.0
|
L
 12.4%
H
33.4
43.7
|
L
 -1.9%
H
33.4
47.1
|
L
 -7.8%
H
26.6
50.9
|
L
 -42.3%
H
17
79.9
|
L
 95.3%
H
16.5
93.8
|
L
H
7.6
93.8
|
Exact Sciences Corp |
|
10,601.9
|
56
|
L
 2.3%
H
55.0
56.5
|
L
 8.9%
H
51.2
56.5
|
L
 36.9%
H
41.2
56.5
|
L
 0.6%
H
38.8
57.4
|
L
 -12.7%
H
38.8
72.8
|
L
 37.8%
H
29.3
100.8
|
L
 -26.5%
H
29.3
159.5
|
L
 185.1%
H
4.7
159.5
|
Edap Tms SA Adr |
|
97.6
|
2.6
|
L
 -1.9%
H
2.6
2.7
|
L
 3.6%
H
2.4
2.9
|
L
 107.1%
H
1.3
3.1
|
L
 45.8%
H
1.2
3.1
|
L
 -19.2%
H
1.2
3.3
|
L
 -68.2%
H
1.2
12.7
|
L
 -33.6%
H
1.2
12.7
|
L
 -41.3%
H
1.2
12.7
|
GlucoTrack Inc |
|
4.4
|
4.9
|
L
 5.2%
H
4.6
5.1
|
L
H
4.3
5.1
|
L
 -17.2%
H
4.2
6
|
L
 -49.3%
H
4.2
15.9
|
L
 -99.9%
H
4.2
3756
|
L
 -100.0%
H
4.2
22500
|
L
 -100.0%
H
4.2
46800
|
L
 -100.0%
H
4.2
526500
|
GE HealthCare Tech |
|
35,593.6
|
78.0
|
L
 2.6%
H
75.6
78.4
|
L
 5.2%
H
74.2
79.7
|
L
 6.8%
H
71.1
79.7
|
L
 6.2%
H
69.1
79.7
|
L
 -10.6%
H
57.7
94.8
|
L
H
53
94.8
|
L
H
53
94.8
|
L
H
53
94.8
|
Harvard Bioscience Inc |
|
19.6
|
0.4
|
L
 -2.2%
H
0.4
0.5
|
L
 -6.4%
H
0.4
0.5
|
L
 -8.3%
H
0.4
0.6
|
L
 -24.1%
H
0.4
0.6
|
L
 -84.5%
H
0.3
3.0
|
L
 -86.1%
H
0.3
6.3
|
L
 -86.1%
H
0.3
8.8
|
L
 -90.3%
H
0.3
8.8
|
Hologic |
|
14,764.2
|
66.4
|
L
 1.3%
H
65.5
66.6
|
L
 0.0%
H
65.4
67.6
|
L
 -2.4%
H
65.1
69.1
|
L
 2.8%
H
63.2
69.1
|
L
 -17.0%
H
51.9
84.4
|
L
 -4.0%
H
51.9
87.9
|
L
 7.0%
H
51.9
87.9
|
L
 65.5%
H
26.5
87.9
|
Heart Test Laboratories Inc |
|
8.5
|
3.3
|
L
 0.9%
H
3.2
3.5
|
L
 0.3%
H
3.2
3.5
|
L
 -10.5%
H
3.2
3.9
|
L
 -10.0%
H
2.9
6.5
|
L
 18.4%
H
2.5
6.5
|
L
 -97.6%
H
2.4
395
|
L
H
2.4
600
|
L
H
2.4
600
|
Helius Medical Technologies |
|
7.9
|
7.3
|
L
 7.0%
H
6.8
7.5
|
L
 22.2%
H
5.8
7.5
|
L
 26.0%
H
5.7
7.5
|
L
 -86.8%
H
5.4
35.3
|
L
 -98.8%
H
5.4
1200
|
L
 -100.0%
H
5.4
21363.5
|
L
 -100.0%
H
5.4
1275000
|
L
 -100.0%
H
5.4
27168750
|
Henry Schein |
|
8,434.2
|
69.6
|
L
 3.2%
H
67.2
69.9
|
L
 2.6%
H
67.0
70.7
|
L
 5.2%
H
66.1
70.7
|
L
 -2.2%
H
63
75.8
|
L
 3.7%
H
60.6
82.5
|
L
 -6.4%
H
60.0
89.7
|
L
 8.0%
H
56.3
92.7
|
L
 31.2%
H
41.9
92.7
|
Hyperfine Inc Ordinary Shares |
|
106.1
|
1.4
|
L
 2.3%
H
1.3
1.4
|
L
 20.5%
H
1.1
1.4
|
L
 3.9%
H
1.1
1.6
|
L
 62.7%
H
0.7
1.6
|
L
 32.4%
H
0.5
1.9
|
L
 10.7%
H
0.5
3.3
|
L
H
0.5
16.6
|
L
H
0.5
16.6
|
Integra Lifesciences Holdings |
|
1,205.3
|
15.5
|
L
 0.5%
H
15.3
15.7
|
L
 -1.2%
H
14.9
16.3
|
L
 21.3%
H
12.8
16.3
|
L
 20.6%
H
11.1
16.3
|
L
 -12.1%
H
11.1
27.1
|
L
 -68.8%
H
11.1
60.7
|
L
 -64.3%
H
11.1
77.4
|
L
 -51.7%
H
11.1
77.4
|
Icecure Medical |
|
68.0
|
1.0
|
L
 -1%
H
1.0
1.0
|
L
 -6.6%
H
1.0
1.1
|
L
 25.3%
H
0.7
1.3
|
L
 -3.9%
H
0.7
1.3
|
L
 59.7%
H
0.5
1.7
|
L
 -33.1%
H
0.5
4.7
|
L
 -50.5%
H
0.2
16
|
L
 -27.2%
H
0.2
16
|
SeaStar Medical Holding Corp |
|
24.6
|
0.9
|
L
 1.2%
H
0.8
0.9
|
L
 7.3%
H
0.8
0.9
|
L
 12.8%
H
0.6
0.9
|
L
 -29.0%
H
0.3
1.3
|
L
 -83.0%
H
0.3
5.3
|
L
 -99.7%
H
0.2
550
|
L
H
0.2
550
|
L
H
0.2
550
|
ICU Medical Inc |
|
3,333.3
|
135.0
|
L
 1.1%
H
132.2
136.6
|
L
 7.5%
H
126.1
136.6
|
L
 24.9%
H
107.5
136.6
|
L
 0.4%
H
107
139.4
|
L
 -20.8%
H
107
196.3
|
L
 -21.7%
H
78.4
212.4
|
L
 -29.7%
H
78.4
282
|
L
 18.9%
H
78.4
321.7
|
IDEXX Laboratories |
|
51,615.8
|
645.2
|
L
 1.1%
H
637.1
648.3
|
L
 0.7%
H
630.9
655.8
|
L
 -1.1%
H
626.2
665.0
|
L
 23.1%
H
506.9
688.1
|
L
 31.6%
H
356.3
688.1
|
L
 72.4%
H
317.1
688.1
|
L
 76.8%
H
317.1
707.0
|
L
 745.0%
H
63.5
707.0
|
Inspira Technologies Oxy BHN |
|
35.7
|
1.2
|
L
 -7.2%
H
1.1
1.3
|
L
 2.7%
H
1.1
1.3
|
L
 -3.3%
H
1.1
1.5
|
L
 45%
H
0.7
1.7
|
L
 3.6%
H
0.4
1.7
|
L
 -31.8%
H
0.4
2.5
|
L
H
0.4
9.6
|
L
H
0.4
9.6
|
Intercure |
|
84.5
|
1.6
|
L
 -1.9%
H
1.6
1.6
|
L
 -1.9%
H
1.6
1.6
|
L
 -8.3%
H
1.5
1.8
|
L
H
1.4
1.8
|
L
 -21.3%
H
1.2
2.0
|
L
 -67.5%
H
1.0
5.6
|
L
 -63.4%
H
1.0
12.7
|
L
H
1.0
19.4
|
Inogen Inc |
|
231.5
|
8.6
|
L
 2.9%
H
8.3
8.6
|
L
 5.4%
H
8
8.7
|
L
 21.6%
H
7
8.7
|
L
 32.7%
H
5.9
8.7
|
L
 -26.0%
H
5.7
12.9
|
L
 -68.7%
H
4.1
28.4
|
L
 -68.4%
H
4.1
82.4
|
L
 -84.3%
H
4.1
287.8
|
Inmode |
|
969.6
|
15.3
|
L
 2.1%
H
15.0
15.5
|
L
 6.5%
H
14.4
15.5
|
L
 11.2%
H
13.8
15.5
|
L
 7.4%
H
13.1
15.6
|
L
 -9.2%
H
13.1
19.9
|
L
 -53.8%
H
13.1
48.3
|
L
 -9.6%
H
13.1
99.3
|
L
H
6.5
99.3
|
NAYA Biosciences |
|
4.5
|
1.0
|
L
 1.0%
H
1.0
1.0
|
L
 21.4%
H
0.7
1.0
|
L
 -41.7%
H
0.7
1.8
|
L
 -76.7%
H
0.7
4.6
|
L
 -96.0%
H
0.7
51.1
|
L
 -99.9%
H
0.7
1188
|
L
 -100.0%
H
0.7
8856
|
L
 -100.0%
H
0.7
34329.6
|
IRIDEX Corp |
|
23.3
|
1.4
|
L
 3.8%
H
1.3
1.4
|
L
 3.8%
H
1.3
1.5
|
L
 8.7%
H
1.1
1.5
|
L
 47.3%
H
0.9
1.6
|
L
 -32.5%
H
0.8
2.0
|
L
 -46.5%
H
0.8
3.7
|
L
 -27.9%
H
0.8
9.7
|
L
 -81.0%
H
0.8
16.6
|
Iradimed Corp |
|
944.7
|
74.3
|
L
 3.9%
H
71.7
74.4
|
L
 3.0%
H
71
74.4
|
L
 6.1%
H
69.4
74.4
|
L
 23.8%
H
55.1
74.4
|
L
 58.9%
H
46.7
74.4
|
L
 118.6%
H
26
74.4
|
L
 233.8%
H
20.5
74.4
|
L
 201.7%
H
7.9
74.4
|
iRhythm Technologies Inc |
|
5,816.1
|
181.0
|
L
 -0.6%
H
179.1
184.4
|
L
 -0.6%
H
179.1
187.6
|
L
 12.8%
H
152.1
187.6
|
L
 22.8%
H
129.5
187.6
|
L
 141.9%
H
55.9
187.6
|
L
 13.7%
H
55.9
187.6
|
L
 -13.9%
H
41.7
286.2
|
L
H
22.2
286.2
|
Intuitive Surgical |
|
163,411.5
|
455.9
|
L
 1.3%
H
449.8
463.1
|
L
 0.3%
H
446.5
472.7
|
L
 -3.4%
H
434.8
487.2
|
L
 -12.7%
H
434.8
550.7
|
L
 -7.2%
H
425
616
|
L
 106.0%
H
180.1
616
|
L
 94.7%
H
180.1
616
|
L
 696.1%
H
49.7
616
|
Jowell Global |
|
3.9
|
1.8
|
L
 4.1%
H
1.6
1.8
|
L
 -9.1%
H
1.5
2.2
|
L
 -6.3%
H
1.5
2.2
|
L
 -6.8%
H
1.5
3.0
|
L
 30.7%
H
1.2
3.7
|
L
 -92.3%
H
1
53.8
|
L
H
1
412.5
|
L
H
1
412.5
|
Kewaunee Scientific |
|
127.0
|
43.1
|
L
 -21.2%
H
42.0
48.2
|
L
 -20.4%
H
42.0
57.9
|
L
 -21.6%
H
42.0
60.9
|
L
 9.2%
H
36.1
60.9
|
L
 0.1%
H
30.3
71.3
|
L
 138.5%
H
14.6
71.3
|
L
 376.0%
H
8.1
71.3
|
L
 160.9%
H
7.0
71.3
|
OrthoPediatrics corp |
|
509.7
|
20.3
|
L
 5.4%
H
19.1
20.4
|
L
 -1.8%
H
19.1
21.4
|
L
 8.1%
H
18.6
22.8
|
L
 -8.0%
H
16.6
23.7
|
L
 -34.8%
H
16.6
33.1
|
L
 -60.9%
H
16.6
53.5
|
L
 -52.2%
H
16.6
73.9
|
L
H
14
73.9
|
KORU Medical Systems Inc |
|
185.9
|
4.0
|
L
 -0.5%
H
4
4.1
|
L
 -2.0%
H
4.0
4.1
|
L
 -0.5%
H
4.0
4.4
|
L
 25.6%
H
2.9
4.4
|
L
 60.2%
H
1.9
5.1
|
L
 60.8%
H
1.9
5.1
|
L
 -47.1%
H
1.8
8.2
|
L
 1196.8%
H
0.3
12.8
|
Standard BioTools Inc |
|
508.1
|
1.3
|
L
 3.9%
H
1.3
1.4
|
L
 3.1%
H
1.3
1.4
|
L
 3.9%
H
1.2
1.4
|
L
 23.2%
H
1.0
1.6
|
L
 -32.8%
H
0.9
2.3
|
L
 -4.3%
H
0.9
3.2
|
L
 -79.9%
H
0.9
9.2
|
L
 -88.5%
H
0.9
14.9
|
LivaNova PLC |
|
3,130.8
|
57.3
|
L
 1.5%
H
56.4
57.4
|
L
 -1.4%
H
56.4
58.9
|
L
 15.7%
H
49.8
58.9
|
L
 22.8%
H
41.0
58.9
|
L
 20.8%
H
32.5
58.9
|
L
 -0.7%
H
32.5
64.5
|
L
 27.5%
H
32.5
93.9
|
L
H
32.5
131.5
|
Lemaitre Vascular Inc |
|
2,133.1
|
94.2
|
L
 1.7%
H
92.3
94.4
|
L
 -2.9%
H
91.8
98.9
|
L
 1.7%
H
90.8
101.0
|
L
 13.3%
H
79
101.0
|
L
 8.6%
H
71.4
109.6
|
L
 83.3%
H
41.8
109.6
|
L
 205.5%
H
30.0
109.6
|
L
 604.3%
H
11.8
109.6
|
LENSAR Inc |
|
144.8
|
12.1
|
L
H
12.1
12.2
|
L
 -0.3%
H
12
12.5
|
L
 -6.9%
H
11.6
13.1
|
L
 -6.4%
H
11.6
13.5
|
L
 145.1%
H
3.8
17.3
|
L
 145.5%
H
1.8
17.3
|
L
H
1.8
17.3
|
L
H
1.8
17.3
|
Lantheus Holdings Inc |
|
3,739.0
|
55.0
|
L
 4.7%
H
52.1
55.1
|
L
 2.2%
H
51.9
55.2
|
L
 -1.9%
H
51.4
60.1
|
L
 -31.9%
H
47.3
85.3
|
L
 -46.1%
H
47.3
118.2
|
L
 -35.3%
H
47.3
126.9
|
L
 337.5%
H
10.5
126.9
|
L
 687.8%
H
1.8
126.9
|
Lucid Diagnostics Inc |
|
109.0
|
1.1
|
L
 4.9%
H
1.0
1.1
|
L
 -22.5%
H
1.0
1.5
|
L
 7%
H
1.0
1.5
|
L
 -16.4%
H
1.0
1.5
|
L
 28.9%
H
0.8
1.8
|
L
 -52.9%
H
0.6
2.4
|
L
H
0.6
13.5
|
L
H
0.6
13.5
|
Pulmonx Corp |
|
68.9
|
1.7
|
L
 5.0%
H
1.6
1.7
|
L
 -2.9%
H
1.6
1.8
|
L
 9.0%
H
1.5
1.9
|
L
 -48.2%
H
1.5
3.9
|
L
 -78.2%
H
1.5
9.4
|
L
 -91.7%
H
1.5
20.9
|
L
H
1.5
69.5
|
L
H
1.5
69.5
|
Masimo Corp |
|
7,942.8
|
146.2
|
L
 0.3%
H
144.9
149.4
|
L
 2.2%
H
142.1
149.9
|
L
 -0.8%
H
135.3
158.3
|
L
 -12.5%
H
135.3
174.0
|
L
 28.0%
H
111.0
194.9
|
L
 -6.4%
H
75.2
198
|
L
 -31.7%
H
75.2
305.2
|
L
 251.1%
H
33.0
305.2
|
908 Devices Inc |
|
206.4
|
5.7
|
L
 0.4%
H
5.6
5.8
|
L
 4%
H
5.4
5.8
|
L
 -11.0%
H
5.3
7.4
|
L
 -21.4%
H
5.3
8.1
|
L
 63.9%
H
1.8
8.1
|
L
 -71.0%
H
1.8
20.0
|
L
H
1.8
79.6
|
L
H
1.8
79.6
|
Mimedx Group Inc |
|
1,056.4
|
7.1
|
L
 3.6%
H
6.9
7.1
|
L
 0.7%
H
6.8
7.3
|
L
 1.4%
H
6.8
7.5
|
L
 11.2%
H
5.8
8.0
|
L
 15.4%
H
5.5
10.1
|
L
 110.6%
H
2.4
10.1
|
L
 21.6%
H
2.4
16.0
|
L
 -29.4%
H
1.0
18.3
|
Monogram Orthopaedics Inc |
|
232.8
|
5.7
|
L
 -1.6%
H
5.7
5.8
|
L
 -3.5%
H
5.7
6.0
|
L
 6.5%
H
5.3
6.0
|
L
 117.1%
H
2.6
6.0
|
L
 70.5%
H
1.9
6.0
|
L
H
1.5
49.0
|
L
H
1.5
49.0
|
L
H
1.5
49.0
|
Meihua International Medical |
|
13.4
|
0.4
|
L
 2.4%
H
0.4
0.4
|
L
 10.5%
H
0.4
0.5
|
L
 2.4%
H
0.4
0.5
|
L
 10.5%
H
0.3
0.5
|
L
 -62.2%
H
0.3
1.2
|
L
 -89.8%
H
0.3
45.5
|
L
H
0.3
45.5
|
L
H
0.3
45.5
|
Mesa Laboratories Inc |
|
347.1
|
63.1
|
L
 6%
H
58.8
64.4
|
L
 -1.9%
H
58.8
68
|
L
 4.3%
H
58.8
73.2
|
L
 -39.6%
H
55.5
104.4
|
L
 -47.2%
H
55.5
155.1
|
L
 -62.2%
H
55.5
206.4
|
L
 -74.4%
H
55.5
333.4
|
L
 -42.8%
H
55.5
333.4
|
Merit Medical Systems Inc |
|
5,342.2
|
90.2
|
L
 1.6%
H
88.8
90.4
|
L
 -2.1%
H
88.4
93.3
|
L
 7.3%
H
84
93.3
|
L
 -4.4%
H
81.0
96.7
|
L
 -7.1%
H
81.0
111.5
|
L
 46.8%
H
52.8
111.5
|
L
 105.2%
H
39.4
111.5
|
L
 276.2%
H
15.5
111.5
|
Modular Medical Inc |
|
38.7
|
0.7
|
L
 1.5%
H
0.7
0.7
|
L
 -1.4%
H
0.7
0.8
|
L
 -2.8%
H
0.7
0.8
|
L
 -18.6%
H
0.6
0.9
|
L
 -66.7%
H
0.6
2.5
|
L
 -84.4%
H
0.6
4.6
|
L
 -2.8%
H
0.6
19.5
|
L
 -13.6%
H
0.6
19.5
|
Myriad Genetics Inc |
|
714.6
|
7.7
|
L
 11.3%
H
6.9
7.7
|
L
 13.1%
H
6.4
7.7
|
L
 24.1%
H
5.2
7.7
|
L
 48.3%
H
3.8
7.7
|
L
 -70.8%
H
3.8
29.3
|
L
 -66.3%
H
3.8
29.3
|
L
 -42.2%
H
3.8
37.0
|
L
 -80.0%
H
3.8
50.4
|
MDxHealth SA ADR |
|
-
|
3.8
|
L
 10.1%
H
3.6
3.9
|
L
 8.5%
H
3.5
3.9
|
L
 33.0%
H
2.6
3.9
|
L
 83.3%
H
1.9
3.9
|
L
 47.3%
H
1.4
3.9
|
L
 -53.3%
H
1.4
8.5
|
L
H
1.4
13.2
|
L
H
1.4
13.2
|
NanoVibronix Inc |
|
5.0
|
6.3
|
L
 5.9%
H
5.8
6.4
|
L
 20.0%
H
5.0
6.4
|
L
 -19.0%
H
4.7
8
|
L
 -47.9%
H
0.7
13.2
|
L
 -91.2%
H
0.7
162.5
|
L
 -99.4%
H
0.7
1419.2
|
L
 -99.5%
H
0.7
9218
|
L
 -99.9%
H
0.7
18700
|
ENDRA Life Sciences Inc |
|
3.5
|
4.6
|
L
 8.5%
H
4.3
4.7
|
L
 8.2%
H
4
4.7
|
L
 9.0%
H
4
4.9
|
L
 36.8%
H
3.1
12.0
|
L
 1744%
H
0.2
12.0
|
L
 -98.7%
H
0.0
370
|
L
 -99.4%
H
0.0
3100
|
L
H
0.0
5880
|
Neogen Corp |
|
1,246.8
|
5.7
|
L
 2.7%
H
5.6
5.8
|
L
H
5.5
5.9
|
L
 12.3%
H
5.1
5.9
|
L
 0.7%
H
4.6
5.9
|
L
 -62.4%
H
3.9
18.0
|
L
 -68.9%
H
3.9
24.1
|
L
 -84.6%
H
3.9
48.9
|
L
 -71.8%
H
3.9
48.9
|
Nephros Inc |
|
44.6
|
4.2
|
L
 -1.4%
H
4.1
4.3
|
L
 5.3%
H
3.8
4.6
|
L
 -6.2%
H
3.6
5.0
|
L
 10.8%
H
2.9
5
|
L
 123.9%
H
1.4
5
|
L
 234.1%
H
0.9
5
|
L
 -39.0%
H
0.9
11.7
|
L
 -0.5%
H
0.9
11.7
|
NeuroOne Medical Technologies |
|
44.5
|
0.9
|
L
H
0.9
0.9
|
L
 21.9%
H
0.7
1.0
|
L
 20.3%
H
0.7
1.0
|
L
 58.9%
H
0.6
1.1
|
L
 8.5%
H
0.4
1.4
|
L
 -51.6%
H
0.4
2.9
|
L
 -74.4%
H
0.4
13.5
|
L
H
0.4
30
|
Nano X Imaging |
|
253.8
|
4.0
|
L
 5.0%
H
3.8
4.0
|
L
 6.7%
H
3.6
4.1
|
L
 -15.7%
H
3.6
4.9
|
L
 -26.6%
H
3.6
5.7
|
L
 -36.0%
H
3.6
11
|
L
 -67.3%
H
3.6
22.7
|
L
 -93.8%
H
3.6
94.8
|
L
H
3.6
94.8
|
NeuroPace Inc |
|
331.1
|
10.0
|
L
 3.5%
H
9.7
10.1
|
L
 4.2%
H
9.4
10.2
|
L
 12.6%
H
7.6
10.2
|
L
 -15.4%
H
7.6
12.0
|
L
 39.4%
H
5.5
19.0
|
L
 140.0%
H
1.2
19.0
|
L
H
1.2
27.4
|
L
H
1.2
27.4
|
InspireMD Inc |
|
101.0
|
2.4
|
L
 0.8%
H
2.4
2.4
|
L
 -0.8%
H
2.4
2.5
|
L
 -6.2%
H
2.3
2.6
|
L
 -1.2%
H
2.0
2.9
|
L
 -9.7%
H
2.0
3.8
|
L
 32.2%
H
0.8
3.9
|
L
 -55.3%
H
0.8
22.2
|
L
 -100.0%
H
0.8
1476562.5
|
Nortech Systems Inc |
|
26.2
|
9.4
|
L
 1.2%
H
9.3
9.5
|
L
 2.4%
H
9.0
9.5
|
L
 10.6%
H
8.5
9.7
|
L
 3.5%
H
7.6
10.9
|
L
 -19.0%
H
7.3
13.9
|
L
 -21.7%
H
7.3
19.2
|
L
 102.2%
H
4.2
19.6
|
L
 126.5%
H
1.7
19.6
|
Natera Inc |
|
23,855.1
|
173.8
|
L
 2.4%
H
169.6
174.2
|
L
 4.4%
H
164.8
176.8
|
L
 10.7%
H
152.6
176.8
|
L
 4.2%
H
131.8
176.8
|
L
 40.4%
H
117.3
183
|
L
 228.4%
H
34
183
|
L
 191.6%
H
26.1
183
|
L
 968.9%
H
6.5
183
|
Nutriband Inc |
|
82.7
|
6.9
|
L
 15.5%
H
6.0
7.5
|
L
 11.2%
H
5.9
7.5
|
L
 1.2%
H
5.8
7.5
|
L
 -8.8%
H
5.8
11.7
|
L
 80.5%
H
3.7
11.8
|
L
 63.1%
H
1.5
11.8
|
L
 -4.9%
H
0.9
27.4
|
L
H
0.9
43.5
|
Nuwellis Inc |
|
3.8
|
4.2
|
L
 2.4%
H
4.0
4.4
|
L
 -13.9%
H
3.7
4.9
|
L
 -15.1%
H
3.7
6.7
|
L
 -72.8%
H
3.7
26.0
|
L
 -91.1%
H
3.7
176.0
|
L
 -100.0%
H
3.7
116176.2
|
L
 -100.0%
H
3.7
1847790
|
L
 -100.0%
H
3.7
10000000000
|
NovoCure |
|
1,423.2
|
12.7
|
L
 4.3%
H
12.2
12.8
|
L
 6.3%
H
12.0
13.7
|
L
 16.8%
H
10.9
13.7
|
L
 -26.7%
H
10.9
18.7
|
L
 -26.1%
H
10.9
34.1
|
L
 -85.7%
H
10.9
120.0
|
L
 -85.7%
H
10.9
232.8
|
L
H
6.0
232.8
|
enVVeno Medical Corporation |
|
15.2
|
0.8
|
L
 9.7%
H
0.7
0.8
|
L
H
0.7
0.8
|
L
 -82.5%
H
0.7
5.1
|
L
 -82.4%
H
0.7
5.6
|
L
 -84.9%
H
0.7
5.7
|
L
 -89.2%
H
0.7
7.9
|
L
 -94.4%
H
0.7
17.7
|
L
H
0.7
141
|
Nexalin Technology Inc |
|
15.2
|
0.9
|
L
 7.4%
H
0.8
0.9
|
L
 2.4%
H
0.8
0.9
|
L
 -2.3%
H
0.7
1.2
|
L
 -28.7%
H
0.7
1.3
|
L
 6.1%
H
0.6
4.5
|
L
H
0.3
4.5
|
L
H
0.3
4.5
|
L
H
0.3
4.5
|
Nyxoah SA |
|
208.4
|
5.6
|
L
 -0.4%
H
5.5
5.7
|
L
 -2.6%
H
5.5
6.1
|
L
 -20.9%
H
5.5
7.2
|
L
 -28.4%
H
5.5
8.6
|
L
 -27.0%
H
5.5
11.9
|
L
 -26.5%
H
4
20
|
L
H
4
37
|
L
H
4
37
|
Nanobiotix ADR |
|
479.7
|
10.0
|
L
 6.4%
H
9.9
10.2
|
L
 16.8%
H
8.3
10.2
|
L
 35.4%
H
7.0
10.6
|
L
 95.9%
H
4.2
10.6
|
L
 95.9%
H
2.8
10.6
|
L
 136.9%
H
1.8
11
|
L
H
1.8
21.6
|
L
H
1.8
21.6
|
Orchestra BioMed Holdings Inc |
|
141.4
|
2.6
|
L
 0.4%
H
2.6
2.7
|
L
 -4.4%
H
2.6
2.8
|
L
 4.0%
H
2.4
3.0
|
L
 -17.4%
H
2.4
3.5
|
L
 -54.0%
H
2.4
6.5
|
L
 -73.5%
H
2.4
23.4
|
L
 -76.4%
H
2.4
23.4
|
L
H
2.4
23.4
|
Orthofix Medical Inc |
|
592.4
|
15
|
L
 5.3%
H
14.3
15.0
|
L
 2.0%
H
14.2
15.0
|
L
 15.9%
H
13.0
15.1
|
L
 31.8%
H
10.2
15.1
|
L
 -13.8%
H
10.2
20.7
|
L
 -30.0%
H
9.6
23.2
|
L
 -46.9%
H
9.6
48.5
|
L
 -59.1%
H
9.6
74.4
|
Outset Medical Inc |
|
251.4
|
14.2
|
L
 4.5%
H
13.4
14.4
|
L
 6.0%
H
13.2
14.4
|
L
 13.8%
H
12.2
14.4
|
L
 -30.7%
H
12.2
21.4
|
L
 85.0%
H
0.5
25.4
|
L
 -95.0%
H
0.5
458.3
|
L
H
0.5
1004.4
|
L
H
0.5
1004.4
|
Organogenesis Holdings Inc |
|
639.4
|
5.0
|
L
 3.7%
H
4.9
5.1
|
L
 0.2%
H
4.7
5.1
|
L
 9.1%
H
4.4
5.2
|
L
 55.1%
H
3.1
5.2
|
L
 96.9%
H
2.5
6.7
|
L
 36.2%
H
1.8
6.7
|
L
 26.6%
H
1.8
24.3
|
L
H
1.8
310.9
|
Orasure Technologies Inc |
|
242.8
|
3.3
|
L
 1.8%
H
3.3
3.4
|
L
 5.4%
H
3.1
3.4
|
L
 19%
H
2.7
3.5
|
L
 13.7%
H
2.7
3.8
|
L
 -21.9%
H
2.4
4.6
|
L
 -20%
H
2.4
8.5
|
L
 -70.6%
H
2.4
17.8
|
L
 -35.3%
H
2.4
23.0
|
Pacific Biosciences of |
|
378.5
|
1.3
|
L
 3.3%
H
1.2
1.3
|
L
 1.6%
H
1.2
1.3
|
L
H
1.2
1.4
|
L
 8.6%
H
1.1
1.8
|
L
 -25%
H
0.9
2.7
|
L
 -81.2%
H
0.9
14.6
|
L
 -82.2%
H
0.9
53.7
|
L
 -74.2%
H
0.9
53.7
|
PAVmed Inc |
|
9.4
|
0.4
|
L
 2.4%
H
0.4
0.5
|
L
 -2.3%
H
0.4
0.5
|
L
 -4.4%
H
0.4
0.5
|
L
 -37.7%
H
0.3
0.7
|
L
 -72.8%
H
0.3
1.9
|
L
 -65.0%
H
0.2
4.4
|
L
 -76.1%
H
0.2
9.7
|
L
H
0.2
15.2
|
ProDex Inc co |
|
114.7
|
35.2
|
L
 -1.5%
H
35
35.9
|
L
 -23.1%
H
35
43.4
|
L
 -8.4%
H
35
48.4
|
L
 -15.8%
H
35
56.5
|
L
 36.8%
H
23.7
70.3
|
L
 74.6%
H
14.5
70.3
|
L
 25.2%
H
12.4
70.3
|
L
 1416.4%
H
2.2
70.3
|
Pulse Biosciences Inc |
|
1,015.9
|
15.1
|
L
 2.2%
H
14.5
15.2
|
L
 -0.5%
H
14.4
15.5
|
L
 1.5%
H
14.4
17.9
|
L
 -9.7%
H
14.2
17.9
|
L
 -11.9%
H
13.8
25
|
L
 832.1%
H
1.4
25
|
L
 34.2%
H
1.2
45.8
|
L
H
1.2
45.8
|
Predictive Oncology Inc |
|
10.9
|
1.0
|
L
H
0.9
1
|
L
 3.3%
H
0.9
1.1
|
L
 30.1%
H
0.7
1.1
|
L
 -5%
H
0.7
1.1
|
L
H
0.6
3.1
|
L
 -88.0%
H
0.6
13.9
|
L
 -94.4%
H
0.6
46
|
L
 -100.0%
H
0.6
33800
|
Precision Optics Corp Inc |
|
33.3
|
4.3
|
L
 0.7%
H
4.3
4.5
|
L
 -5.5%
H
4.3
4.6
|
L
 -10.1%
H
4.3
5.1
|
L
 -10.5%
H
4.1
5.1
|
L
 -18.9%
H
3.5
6.5
|
L
H
3.5
7.9
|
L
H
3.5
7.9
|
L
H
3.5
7.9
|
Insulet |
|
23,788.5
|
337.9
|
L
 0.1%
H
336.0
342.4
|
L
 -2.5%
H
330
353.5
|
L
 10.9%
H
302.4
353.5
|
L
 11.8%
H
276.5
353.5
|
L
 48.4%
H
225.3
353.5
|
L
 25.7%
H
125.8
353.5
|
L
 59.7%
H
125.8
353.5
|
L
 1060.9%
H
23.9
353.5
|
Procept BioRobotics Corp |
|
2,149.8
|
38.6
|
L
 3.0%
H
37.1
39.4
|
L
 0.8%
H
37.1
41.5
|
L
 -0.3%
H
37.1
42.7
|
L
 -37.8%
H
37.1
62.8
|
L
 -50.5%
H
37.1
103.8
|
L
 -23.7%
H
24.8
103.8
|
L
H
15.4
103.8
|
L
H
15.4
103.8
|
Prenetics Global Ordinary |
|
115.5
|
8.9
|
L
 -12.1%
H
8.2
10.5
|
L
 10.6%
H
7.9
10.8
|
L
 10.8%
H
7.2
10.8
|
L
 16.6%
H
6.9
10.8
|
L
 86.5%
H
3.1
12.0
|
L
 -86.1%
H
2.9
63.2
|
L
H
2.9
131.3
|
L
H
2.9
131.3
|
Profound Medical Corp |
|
119.0
|
4.0
|
L
 2.3%
H
3.9
4.0
|
L
 -10.4%
H
3.8
4.4
|
L
 -29.7%
H
3.8
6.0
|
L
 -41.7%
H
3.8
7.0
|
L
 -50.2%
H
3.8
9.2
|
L
 -26.7%
H
3.1
15.5
|
L
 -72.4%
H
3.1
29.0
|
L
H
0.0
29.0
|
QuidelOrtho Corporation |
|
2,032.9
|
29.9
|
L
 8.4%
H
27.6
30.0
|
L
 7.7%
H
27.4
30.0
|
L
 26.7%
H
23.7
30.0
|
L
 -3.3%
H
22.1
32.7
|
L
 -33.2%
H
22.1
49.5
|
L
 -65.2%
H
22.1
102
|
L
 -81.4%
H
22.1
288.7
|
L
 44.3%
H
13.2
306.7
|
Quanterix Corp |
|
222.6
|
4.8
|
L
 10.6%
H
4.3
4.8
|
L
 10.9%
H
4.3
4.8
|
L
 4.6%
H
4.3
5.4
|
L
 -28.1%
H
4.2
7.1
|
L
 -60.3%
H
4.1
15.9
|
L
 -52.6%
H
4.1
29.7
|
L
 -84.9%
H
4.1
92.6
|
L
H
4.1
92.6
|
AVITA Medical Inc |
|
118.3
|
4.4
|
L
 5.0%
H
4.2
4.4
|
L
 2.1%
H
4.1
4.4
|
L
 -8.9%
H
4.1
6
|
L
 -27.7%
H
3.6
6.4
|
L
 -54.2%
H
3.6
14.2
|
L
 -31.6%
H
3.6
21.7
|
L
 -83.3%
H
3.6
29.3
|
L
 -14.1%
H
3.6
55.4
|
Rockwell Medical Inc |
|
58.2
|
1.7
|
L
 2.4%
H
1.6
1.7
|
L
 0.6%
H
1.5
1.8
|
L
 79.8%
H
1.0
2.1
|
L
 70.7%
H
0.8
2.1
|
L
 -58.8%
H
0.8
5.2
|
L
 1.8%
H
0.8
6.2
|
L
 -87.5%
H
0.8
21.8
|
L
 -98.7%
H
0.8
148.5
|
Vyome Holdings Inc |
|
198.8
|
7.5
|
L
 -6.2%
H
7.3
8.2
|
L
 -3.1%
H
7.3
8.5
|
L
 301.1%
H
1.9
12.9
|
L
 229.3%
H
1.9
12.9
|
L
 -19.7%
H
0.3
12.9
|
L
 -99.3%
H
0.3
1299.5
|
L
 -99.9%
H
0.3
93699
|
L
H
0.3
1381560
|
Rewalk Robotics |
|
34.9
|
0.6
|
L
 3.6%
H
0.6
0.6
|
L
 3.6%
H
0.5
0.6
|
L
 -15.9%
H
0.5
0.7
|
L
 -51.7%
H
0.5
1.2
|
L
 -55.4%
H
0.5
1.3
|
L
 -91.4%
H
0.5
9.1
|
L
 -92.3%
H
0.5
42
|
L
 -100.0%
H
0.5
3045
|
Sanmina Corp |
|
6,274.2
|
117.8
|
L
 -4.0%
H
117.5
123
|
L
 -1.8%
H
116.2
123
|
L
 -1.2%
H
108.4
125.8
|
L
 34.1%
H
85.7
125.8
|
L
 80.1%
H
63.7
125.8
|
L
 141.8%
H
43.4
125.8
|
L
 345.7%
H
23.8
125.8
|
L
 493.5%
H
16.3
125.8
|
Sight Sciences Inc |
|
189.6
|
3.6
|
L
 6.2%
H
3.4
3.7
|
L
 -3.0%
H
3.4
3.9
|
L
 -12.1%
H
3.4
4.3
|
L
 -13.6%
H
3.1
4.5
|
L
 -45.0%
H
2.0
7.0
|
L
 -51.4%
H
1.0
15.3
|
L
H
1.0
42.6
|
L
H
1.0
42.6
|
Sotera Health Co |
|
4,578.8
|
16.1
|
L
 2.4%
H
15.8
16.2
|
L
 4%
H
15.5
16.2
|
L
 14.7%
H
14.0
16.6
|
L
 33.7%
H
10.8
16.6
|
L
 -0.4%
H
9.5
17.0
|
L
 2.9%
H
5.8
19.4
|
L
H
5.8
30.4
|
L
H
5.8
30.4
|
SIBONE Inc |
|
704.1
|
16.3
|
L
 4.2%
H
15.5
16.4
|
L
 -0.2%
H
15.5
16.6
|
L
 6.0%
H
15.2
16.9
|
L
 -13.2%
H
15.1
19.1
|
L
 8.2%
H
11.7
20.1
|
L
 -6.0%
H
11.1
29.5
|
L
 -25.5%
H
11.1
37.2
|
L
H
7.2
37.2
|
SINTX Technologies Inc |
|
12.5
|
4.5
|
L
 4.1%
H
4.3
4.7
|
L
 3.7%
H
3.9
6.1
|
L
 57.1%
H
2.8
6.8
|
L
 57.1%
H
2.3
6.8
|
L
 38.0%
H
1.7
8.6
|
L
 -99.9%
H
0.1
8800
|
L
 -100.0%
H
0.1
68800
|
L
 -100.0%
H
0.1
50544000
|
Beauty Health Company The |
|
313.3
|
2.5
|
L
 7.4%
H
2.3
2.5
|
L
 22.9%
H
2.0
2.5
|
L
 11.8%
H
1.9
2.6
|
L
 55.4%
H
1.4
2.6
|
L
 72.7%
H
0.8
2.6
|
L
 -80.3%
H
0.8
14
|
L
H
0.8
30.2
|
L
H
0.8
30.2
|
Semler Scientific Inc |
|
422.5
|
28.5
|
L
 1.9%
H
27.8
29.6
|
L
 1.6%
H
27.8
29.6
|
L
 -19.1%
H
27.6
35.9
|
L
 -10.0%
H
27.6
48.8
|
L
 20.2%
H
21.8
81.6
|
L
 -37.7%
H
19.1
81.6
|
L
 -44.0%
H
19.1
153.2
|
L
 1064.9%
H
1.1
153.2
|
Sanara MedTech Inc |
|
314.1
|
35.3
|
L
 4.5%
H
34.1
35.5
|
L
 3.6%
H
33.1
36.0
|
L
 31.4%
H
25.8
36.0
|
L
 21.9%
H
23.5
36.0
|
L
 5.3%
H
23.5
39.1
|
L
 9.4%
H
23.5
50.2
|
L
 7.8%
H
17.4
53.9
|
L
 300.9%
H
2
75
|
Surmodics Inc |
|
461.4
|
32.3
|
L
 0.5%
H
31.6
32.5
|
L
 -3.4%
H
31.3
34.0
|
L
 -15.1%
H
31.3
38.6
|
L
 11.3%
H
28.1
38.6
|
L
 -17.7%
H
26
40.4
|
L
 -2.1%
H
16
42.4
|
L
 -16.7%
H
16
62.3
|
L
 38.9%
H
16
82.4
|
Sensus Healthcare Inc |
|
53.3
|
3.2
|
L
 1.3%
H
3.2
3.3
|
L
 1.9%
H
3.1
3.3
|
L
 1.9%
H
3.0
3.5
|
L
 -36.5%
H
3.0
5.9
|
L
 -44.9%
H
3.0
9.3
|
L
 -75.1%
H
1.8
15.2
|
L
 17.8%
H
1.8
15.3
|
L
H
1.8
15.3
|
STRATA Skin Sciences Inc |
|
8.3
|
1.6
|
L
 -3.1%
H
1.6
1.7
|
L
 -7.7%
H
1.5
1.9
|
L
 -17.4%
H
1.5
3.9
|
L
 -32.3%
H
1.5
3.9
|
L
 -50.9%
H
1.5
3.9
|
L
 -84.0%
H
1.5
41
|
L
 -89.2%
H
1.5
41
|
L
 -97.4%
H
1.5
76.5
|
Staar Surgical Co |
|
1,391.4
|
28.1
|
L
 1.5%
H
27.6
28.1
|
L
 1.1%
H
27.5
28.4
|
L
 2.9%
H
27.2
30.8
|
L
 60.7%
H
16.2
30.8
|
L
 -7.4%
H
13.5
38.6
|
L
 -71.0%
H
13.5
96.9
|
L
 -44.9%
H
13.5
163.1
|
L
 244.5%
H
5.0
163.1
|
Neuronetics Inc |
|
228.8
|
3.5
|
L
 0.3%
H
3.4
3.6
|
L
 4.5%
H
3
3.7
|
L
 -11.7%
H
3
4
|
L
 -9.4%
H
3
4.9
|
L
 367.6%
H
0.5
5.9
|
L
 1.8%
H
0.5
7.0
|
L
 -16.6%
H
0.5
22.4
|
L
H
0.5
39.4
|
Star Equity Holdings Inc |
|
27.5
|
8.5
|
L
 -13.7%
H
8.4
11.8
|
L
 -13.6%
H
8.4
11.8
|
L
 327%
H
2.0
11.8
|
L
 318.6%
H
1.9
11.8
|
L
 104.8%
H
1.7
11.8
|
L
 65.8%
H
1.7
11.8
|
L
 -35.1%
H
1.7
27
|
L
 -95.7%
H
1.7
346
|
Sharps Technology Inc |
|
238.8
|
9.3
|
L
 0.5%
H
8.8
10.9
|
L
 -11%
H
8.8
11.0
|
L
 63.4%
H
4.5
18.2
|
L
 54.2%
H
4.4
18.2
|
L
 -99.5%
H
0.0
1782
|
L
 -99.9%
H
0.0
13464
|
L
H
0.0
23892
|
L
H
0.0
23892
|
Tactile Systems Technology Inc |
|
305.6
|
13.7
|
L
 3.4%
H
13.2
13.8
|
L
 2.2%
H
13.1
13.8
|
L
 12.7%
H
12.1
13.8
|
L
 36.6%
H
9.4
13.8
|
L
 4.3%
H
8.6
21.1
|
L
 59.2%
H
6.5
26.1
|
L
 -59.7%
H
6.3
64.5
|
L
H
6.3
76.6
|
TELA Bio Inc |
|
64.2
|
1.6
|
L
 3.2%
H
1.6
1.7
|
L
 1.9%
H
1.5
1.7
|
L
 -12.9%
H
1.4
1.9
|
L
 -13.4%
H
1.4
2.2
|
L
 -38.6%
H
0.9
3.3
|
L
 -81.5%
H
0.9
13.2
|
L
 -89.8%
H
0.9
18
|
L
H
0.9
23.5
|
Tivic Health Systems Inc |
|
4.8
|
3.1
|
L
 2.7%
H
2.9
3.1
|
L
 5.5%
H
2.8
3.1
|
L
 -13.8%
H
2.8
5.6
|
L
 -19.4%
H
2.8
5.6
|
L
 -36.8%
H
2.4
15.6
|
L
 -99.9%
H
2.4
3400
|
L
H
2.4
11050
|
L
H
2.4
11050
|
Treace Medical Concepts Inc |
|
470.0
|
7.4
|
L
 6.3%
H
6.9
7.5
|
L
 3.8%
H
6.9
7.6
|
L
 16.4%
H
6.3
7.8
|
L
 20.6%
H
5.2
7.8
|
L
 43.9%
H
4.5
10.8
|
L
 -68.4%
H
3.9
28.0
|
L
H
3.9
37.2
|
L
H
3.9
37.2
|
Transmedics Group Inc |
|
3,988.2
|
117.0
|
L
 8.5%
H
108
119.4
|
L
 12.4%
H
101
119.4
|
L
 -8.1%
H
101
133.5
|
L
 -18.1%
H
98.9
145.5
|
L
 -18.7%
H
55
169.3
|
L
 119.1%
H
36.4
177.4
|
L
 604.3%
H
10
177.4
|
L
H
10
177.4
|
Tandem Diabetes Care Inc |
|
864.2
|
12.8
|
L
 3.4%
H
12.4
13.2
|
L
 3.2%
H
12.1
13.2
|
L
 26.4%
H
10.3
13.2
|
L
 -40.7%
H
10.0
21.4
|
L
 -70.1%
H
10.0
47.6
|
L
 -77.2%
H
10.0
59.9
|
L
 -88.0%
H
10.0
155.9
|
L
 -89.9%
H
2.1
155.9
|
Trinity Biotech Plc ADR |
|
4.5
|
1.2
|
L
 3.5%
H
1.2
1.3
|
L
 4.4%
H
1.1
1.3
|
L
 -94.2%
H
1.1
86
|
L
 -93.1%
H
1.1
86
|
L
 -97.0%
H
1.1
86
|
L
 -99.8%
H
1.1
881.3
|
L
 -99.9%
H
1.1
4262.5
|
L
 -100.0%
H
1.1
9362.5
|
Utah Medical Products Inc |
|
200.5
|
62.5
|
L
 2.9%
H
60.8
63.3
|
L
 -0.3%
H
60.6
64.2
|
L
 11.2%
H
55.3
64.2
|
L
 9.7%
H
52
64.2
|
L
 -5.4%
H
51.3
69.0
|
L
 -31.9%
H
51.3
109.5
|
L
 -20.4%
H
51.3
133.9
|
L
 19.6%
H
50.4
133.9
|
Vivani Medical Inc |
|
71.1
|
1.2
|
L
 -1.6%
H
1.2
1.3
|
L
 -12.4%
H
1.2
1.4
|
L
 -4.8%
H
1.1
1.4
|
L
 0.8%
H
1.1
1.8
|
L
 -4%
H
0.9
1.8
|
L
 -57.4%
H
0.8
7.8
|
L
 -46.4%
H
0.8
60
|
L
 -99.5%
H
0.8
252.5
|
Veracyte Inc |
|
2,506.5
|
31.9
|
L
 3.4%
H
30.8
32.3
|
L
 1.1%
H
30.7
32.8
|
L
 13.8%
H
27.8
32.8
|
L
 14.1%
H
22.6
32.8
|
L
 5.1%
H
22.6
47.3
|
L
 59.7%
H
14.9
47.3
|
L
 4.1%
H
14.9
86.0
|
L
 237.9%
H
4.2
86.0
|
Venus Concept Inc |
|
4.3
|
2.3
|
L
 2.2%
H
2.3
2.3
|
L
 1.8%
H
2.2
2.3
|
L
 -5.7%
H
2.1
2.7
|
L
 -8.3%
H
2.1
3.1
|
L
 329.6%
H
0.3
14.5
|
L
 -77.9%
H
0.3
14.5
|
L
 -92.7%
H
0.3
51.6
|
L
H
0.3
2688.8
|
Varex Imaging Corp |
|
477.5
|
11.5
|
L
 4.9%
H
10.8
11.5
|
L
 -1.4%
H
10.8
12.0
|
L
 17.7%
H
9.7
12.0
|
L
 31.9%
H
6.8
12.0
|
L
 0.5%
H
6.8
16.9
|
L
 -47.4%
H
6.8
23.9
|
L
 7.5%
H
6.8
32.7
|
L
H
6.8
43.8
|
Vivos Therapeutics Inc |
|
27.3
|
3.6
|
L
 -4.5%
H
3.6
3.8
|
L
 -17.3%
H
3.6
4.4
|
L
 -20.5%
H
3.5
4.9
|
L
 64.0%
H
2.0
8.0
|
L
 19.7%
H
2.0
8.0
|
L
 -87.3%
H
1.9
74.1
|
L
H
1.9
360.3
|
L
H
1.9
360.3
|
Wrap Technologies Inc |
|
97.1
|
1.9
|
L
 11.7%
H
1.7
1.9
|
L
 9.8%
H
1.6
1.9
|
L
 46.9%
H
1.3
1.9
|
L
 5.5%
H
1.2
1.9
|
L
 36.4%
H
1.2
2.6
|
L
 2.1%
H
1.0
7.0
|
L
 -75.3%
H
1.0
9.8
|
L
H
1.0
14.4
|
Beyond Air Inc |
|
11.8
|
2.3
|
L
H
2.1
2.5
|
L
 4.2%
H
2.1
4.8
|
L
 -28.5%
H
2.0
4.8
|
L
 -43.5%
H
2.0
5.8
|
L
 -70.8%
H
2.0
13.5
|
L
 -98.8%
H
2.0
198.8
|
L
 -97.8%
H
2.0
328.2
|
L
H
2.0
900
|
DENTSPLY Sirona Inc |
|
2,780.8
|
13.9
|
L
 1.8%
H
13.6
14.0
|
L
 -2.7%
H
13.6
14.9
|
L
 11.3%
H
12.6
14.9
|
L
 -13.5%
H
12.5
17.1
|
L
 -43.6%
H
12.2
27.5
|
L
 -59.0%
H
12.2
43.2
|
L
 -68.4%
H
12.2
69.5
|
L
 -73.5%
H
12.2
69.5
|
XTL Biopharmaceuticals |
|
12.3
|
1.4
|
L
 6.1%
H
1.4
1.5
|
L
 12%
H
1.1
1.5
|
L
 -5.4%
H
1.1
1.5
|
L
 17.7%
H
0.9
1.9
|
L
 -47.4%
H
0.9
2.6
|
L
 2.9%
H
0.8
5.0
|
L
 -32.7%
H
0.8
6.7
|
L
 -84.7%
H
0.6
9.9
|
111 Inc ADR |
|
50.2
|
5.8
|
L
 -4.1%
H
5.5
6.6
|
L
 5.1%
H
5.5
6.6
|
L
 -15.6%
H
5.4
7.5
|
L
 -21.8%
H
5.4
8.7
|
L
 790.8%
H
0.4
11.3
|
L
 76.5%
H
0.4
11.3
|
L
 3.9%
H
0.4
45.9
|
L
H
0.4
45.9
|
ZimVie Inc |
|
532.6
|
18.9
|
L
 0.1%
H
18.9
18.9
|
L
H
18.9
18.9
|
L
 0.3%
H
18.8
19.0
|
L
 98.1%
H
8.3
19.0
|
L
 16.6%
H
8.2
19.0
|
L
 25.0%
H
5.1
22.3
|
L
H
5.1
50.4
|
L
H
5.1
50.4
|
Jin Medical International |
|
104.9
|
0.7
|
L
H
0.7
0.7
|
L
 11.7%
H
0.6
0.7
|
L
 3.1%
H
0.5
0.9
|
L
 -2.9%
H
0.5
0.9
|
L
 -73.9%
H
0.5
4.1
|
L
H
0.5
509.9
|
L
H
0.5
509.9
|
L
H
0.5
509.9
|
Zynex Inc |
|
46.7
|
1.5
|
L
 5.5%
H
1.5
1.6
|
L
 3.4%
H
1.4
1.6
|
L
 8.5%
H
1.4
1.7
|
L
 -24.5%
H
1.2
2.8
|
L
 -80.7%
H
1.2
9.4
|
L
 -83.7%
H
1.2
17.3
|
L
 -89.1%
H
1.2
20.8
|
L
 1000%
H
0.1
27.0
|
HeartBeam Inc |
|
48.7
|
1.4
|
L
 3.7%
H
1.4
1.5
|
L
 1.4%
H
1.3
1.5
|
L
 51.1%
H
0.9
1.5
|
L
 -9.0%
H
0.9
1.8
|
L
 -36.9%
H
0.9
3.5
|
L
 -10.1%
H
0.9
3.5
|
L
 -10.1%
H
0.9
3.5
|
L
 -10.1%
H
0.9
3.5
|
Cencora |
|
58,706.2
|
302.8
|
L
 2.2%
H
295.7
303.6
|
L
 3.5%
H
290.0
303.6
|
L
 4.2%
H
278.2
306.3
|
L
 5.6%
H
273.4
306.3
|
L
 28.2%
H
218.7
309.4
|
L
 105.6%
H
135.1
309.4
|
L
 221.9%
H
92
309.4
|
L
 190.2%
H
68.4
309.4
|
Incannex Healthcare ADR |
|
49.7
|
0.5
|
L
H
0.5
0.5
|
L
 -8.6%
H
0.5
0.6
|
L
 17.8%
H
0.4
0.8
|
L
 165%
H
0.2
1.7
|
L
 -65.4%
H
0.1
3.1
|
L
 -90.3%
H
0.1
5.3
|
L
 -90.3%
H
0.1
5.3
|
L
 -90.3%
H
0.1
5.3
|
Rewalk Robotics |
|
9.1
|
0.6
|
L
 3.6%
H
0.6
0.6
|
L
 3.6%
H
0.5
0.6
|
L
 -15.9%
H
0.5
0.7
|
L
 -51.7%
H
0.5
1.2
|
L
 -81.8%
H
0.5
4
|
L
 -91.4%
H
0.5
9.1
|
L
 -92.3%
H
0.5
42
|
L
 -100.0%
H
0.5
3045
|
Work Medical Technology Group |
|
42.9
|
0.8
|
L
H
0.8
0.8
|
L
 2.6%
H
0.8
0.8
|
L
 1.3%
H
0.7
0.8
|
L
 -9.1%
H
0.7
0.9
|
L
H
0.4
8.5
|
L
H
0.4
8.5
|
L
H
0.4
8.5
|
L
H
0.4
8.5
|
Pheton Holdings Ordinary |
|
13.3
|
0.9
|
L
 -2.1%
H
0.9
1.0
|
L
 -9.7%
H
0.8
1.1
|
L
 19.2%
H
0.5
1.2
|
L
 -94.4%
H
0.5
32
|
L
H
0.5
32
|
L
H
0.5
32
|
L
H
0.5
32
|
L
H
0.5
32
|
Ceribell Inc |
|
423.8
|
11.6
|
L
 1.1%
H
11.4
11.8
|
L
 -6.2%
H
11.4
12.6
|
L
 -4.6%
H
11.2
12.6
|
L
 -34.9%
H
11.2
20.1
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
L
H
10.0
32.8
|
Anteris Technologies Global |
|
180.3
|
5
|
L
 3.7%
H
4.8
5.1
|
L
 25.3%
H
4.0
5.1
|
L
 42.9%
H
3.2
5.1
|
L
 -2.3%
H
2.9
5.2
|
L
H
2.3
8.8
|
L
H
2.3
8.8
|
L
H
2.3
8.8
|
L
H
2.3
8.8
|
Beta Bionics Inc |
|
1,101.5
|
25.3
|
L
 1.9%
H
24.4
25.6
|
L
 26.1%
H
19.9
25.6
|
L
 77.2%
H
14.0
25.6
|
L
 32.6%
H
12.3
25.6
|
L
H
8.9
25.6
|
L
H
8.9
25.6
|
L
H
8.9
25.6
|
L
H
8.9
25.6
|
Wellgistics Health Inc |
|
128.6
|
1.5
|
L
 8.5%
H
1.4
1.6
|
L
 11.7%
H
1.2
1.7
|
L
 106.8%
H
0.6
1.9
|
L
 7.8%
H
0.6
1.9
|
L
H
0.6
7.0
|
L
H
0.6
7.0
|
L
H
0.6
7.0
|
L
H
0.6
7.0
|
Kestra Medical Technologies |
|
944.8
|
18.4
|
L
 1.2%
H
17.6
19.1
|
L
 11.5%
H
16.7
19.1
|
L
 25.6%
H
14.4
19.1
|
L
 -5.6%
H
13.3
20
|
L
H
13.3
26.2
|
L
H
13.3
26.2
|
L
H
13.3
26.2
|
L
H
13.3
26.2
|
Sanuwave Health Inc |
|
317.2
|
37.0
|
L
 5.3%
H
34.6
37.5
|
L
 -4.2%
H
34.3
39.1
|
L
 -13.4%
H
34.3
45.3
|
L
 18.0%
H
28.7
46.6
|
L
 14.6%
H
24.8
46.6
|
L
 14.6%
H
24.8
46.6
|
L
 14.6%
H
24.8
46.6
|
L
 14.6%
H
24.8
46.6
|
SS Innovations International |
|
1,219.7
|
6.3
|
L
 -0.9%
H
6.1
6.4
|
L
 -10%
H
6
7.5
|
L
 0.8%
H
6
7.8
|
L
 50%
H
3.0
11.9
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|
L
H
3.0
22.4
|